Pall Corporation

Clive Glover, strategy director and cell and gene therapy lead at Pall Corporation, explains why we need to take a more holistic approach to gene therapy manufacturing processes. Read more


Pharmaceutical components provider Pall Corporation will distribute off-the-shelf hardware and liner components to the life sciences market from Artesyn Biosolutions - a provider of single-use components and fluid management technologies. Read more


Life sciences manufacturer Pall Corporation has opened a Centre of Excellence (CoE) in Shanghai, Chin, the company has announced. Read more


Martin Smith, chief technology officer of Pall Corporation, explores how data is finally unlocking the door to continuous bioprocessing in medicine manufacture. Read more